Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG;OTCQX: RHHBY) today announced a […]
Additional £5.4 Billion for NHS Covid Response Over Next Six Months
The NHS will receive an extra £5.4 billion over the next six months to support […]
Enesi Pharma Appoints Elizabeth Eagling-Vose, MBA, as Senior Vice President, Operations
Enesi Pharma Ltd (“Enesi”), an innovative biotechnology company developing next-generation vaccination products, targeting infectious diseases […]
Bupa UK Insurance Agrees New Three-year Contract with Circle Health Group, Owner of BMI
Bupa UK Insurance, the leading private healthcare insurance provider and Circle Health Group, Britain’s largest […]
Abbott Expands with Acquisition of Walk Vascular, LLC
Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with […]
XNK Therapeutics Appoints Markus Thor as Chief Business Officer
XNK Therapeutics AB today announced the appointment of Markus Thor as Chief Business Officer, effective September 6th. He […]
Asher Bio Closes $108 Million Series B Financing
Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today […]
Pillar Biosciences Announces Appointment of Randy Pritchard as Chief Executive Officer
Pillar Biosciences, an innovative next-generation sequencing (NGS) solutions in-vitro diagnostics (IVD) company, today announced the […]
Twelve and LanzaTech Partner to Produce the World’s First Polypropylene From CO2
Carbon transformation company Twelve and biotechnology company LanzaTech have partnered to transform CO2 emissions into polypropylene, a key polymer used […]
Oviva Raises $80M in Series C Funding to Give Millions of People Across Europe Access to Personalised, App-based Diet and Lifestyle Coaching
Oviva – the digital health scaleup which provides diet and lifestyle coaching to people who deal […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more